Evidence map›Paper›PMID 38920739›Full record

ArticleCurrent oncology (Toronto, Ont.)2024

The Development and Evaluation of Novel Patient Educational Material for a Variant of Uncertain Significance (VUS) Result in Hereditary Cancer Genes.

Deborah Cragun, Marleah Dean, David Baker, Meghan Kelley, Gillian Hooker, Anne Weidner, Paige Hunt, Tuya Pal

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Deborah CragunCollege of Public Health, University of South Florida, Tampa, FL 33620, USA.
Marleah DeanDepartment of Communication, University of South Florida, Tampa, FL 33620, USA.
David BakerDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN 37212, USA.
Meghan KelleyMorsani College of Medicine, University of South Florida, Tampa, FL 33620, USA.
Gillian HookerDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN 37212, USA.
Anne WeidnerDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN 37212, USA.ORCID 0000-0002-8007-8734
Paige HuntCollege of Public Health, University of South Florida, Tampa, FL 33620, USA.
Tuya PalDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN 37212, USA.

Funding

IMProving Care After Inherited Cancer Testing (IMPACT) StudyU01CA254832 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CRAGUN, DEBORAH LE, PAL, TUYA · 2020 to 2024
$4.0M
NCI NIH HHS 3U01CA254832-04S1NCI NIH HHS U01 CA254832
6 · The paper itself

Abstract

A Variant of Uncertain Significance (VUS) is a difference in the DNA sequence with uncertain consequences for gene function. A VUS in a hereditary cancer gene should not change medical care, yet some patients undergo medical procedures based on their VUS result, highlighting the unmet educational needs among patients and healthcare providers. To address this need, we developed, evaluated, and refined novel educational materials to explain that while VUS results do not change medical care, it remains important to share any personal or family history of cancer with family members given that their personal and family medical history can guide their cancer risk management. We began by reviewing the prior literature and transcripts from interviews with six individuals with a VUS result to identify content and design considerations to incorporate into educational materials. We then gathered feedback to improve materials via a focus group of multidisciplinary experts and multiple rounds of semi-structured interviews with individuals with a VUS result. Themes for how to improve content, visuals, and usefulness were used to refine the materials. In the final round of interviews with an additional 10 individuals with a VUS result, materials were described as relatable, useful, factual, and easy to navigate, and also increased their understanding of cancer gene VUS results.

Indexed as

Patient Education as TopicAdultFemaleGenes, NeoplasmGenetic Predisposition to DiseaseGenetic TestingHumansMaleNeoplasmsambiguitycancer genefamily sharinggeneticsvariant of uncertain significanceVUS

Identifiers

PMID38920739
PMCPMC11202617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.